Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.2736
+0.0036 (1.33%)
At close: Apr 1, 2025, 4:00 PM
0.2856
+0.0120 (4.39%)
After-hours: Apr 1, 2025, 4:34 PM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $8.26 million as of April 1, 2025. Its market cap has decreased by -94.55% in one year.

Market Cap
8.26M
Enterprise Value
-36.76M
1-Year Change
-94.55%
Ranking
Category
Stock Price
$0.27

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $8.26M, a decrease of -85.41%. That is a compound annual growth rate of -18.33%.

History

DateMarket Cap% Change
Mar 31, 20259.00M-42.68%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings